| CODEXIS INC. DL-,01 |
| USA |
| Gesundheit |
| US1920051067 / A0Q2S4 |
| 4QK (Frankfurt) / CDXS (NASDAQ) |
| FRA:4QK, ETR:4QK, 4QK:GR, NASDAQ:CDXS |
| - |
| http://www.codexis.com/ |
|
Codexis Inc. is a biotechnology company focused on enzyme engineering and biocatalysis. Codexis develops and commercializes proprietary protein engineering technologies that create tailored enzymes for pharmaceutical manufacturing, RNA synthesis, mol..
>Volltext.. |
| 98.72 Mio. EUR |
| 113.91 Mio. EUR |
| 70.03 Mio. EUR |
| -14.06 Mio. EUR |
| -27.7 Mio. EUR |
| -0.31 EUR |
| 65.44 Mio. EUR |
| 24.88 Mio. EUR |
| -9.38 Mio. EUR |
| 2.35 |
| 40.16% |
| 51.23% |
| - |
| - |
| - |
| CODEXIS |
| 13.11.26 |
|
||||
|